hPSC cardiomyocyte GiAB induction media
GSK3-pretreated, Activin A/bFGF and BMP4-based RPMI/B27 media for the growth-factor GiAB cardiomyocyte route.
Applicable scenario
Directed cardiomyocyte differentiation of hPSCs using the source's Activin/BMP (GiAB) method. Choose this growth-factor route or the small-molecule GiWi route; do not combine their induction factors unless a separate validated design requires it.
Import to Workspace
Open or scan to import into Workspace, jump to Modules and open this Recipe in the editor.
Formulation tables
Days −3 to −1 · GSK3 pretreatment
| Component | Final concentration / amount | Timing |
|---|---|---|
| mTeSR1 | 2 mL per well | Days −3, −2 and −1 |
| CHIR99021 | 1 µM | Pretreatment before induction |
Day 0 · Activin A/bFGF induction
| Component | Final concentration / amount | Timing |
|---|---|---|
| RPMI/B27 minus insulin | 1 mL per well | Day 0 |
| Activin A | 100 ng/mL | Day 0 |
| bFGF | 10 ng/mL | Day 0 |
| KnockOut Serum Replacement | 1% (vol/vol) | Day 0 |
Day 1 · BMP4 induction
| Component | Final concentration / amount | Timing |
|---|---|---|
| RPMI/B27 minus insulin | 2 mL per well | Day 1 |
| BMP4 | 5 ng/mL | Day 1; do not change medium through day 5 |
Day 5 · medium without induction factors
| Component | Amount | Timing |
|---|---|---|
| RPMI/B27 minus insulin | 2 mL per well | Day 5 |
Day 7 onward · RPMI/B27 with insulin, 510 mL
| Component | Amount | Timing |
|---|---|---|
| RPMI 1640 | 500 mL | Basal medium |
| B27 supplement | 10 mL | Day 7 and every 3 days |
Source values and calculations
- All growth-factor concentrations are reported in Box 1 of the source.
- The source recommends testing 0–10 ng/mL BMP4 when optimizing a cell line; 5 ng/mL is the displayed Box 1 formulation, not a universal optimum.
- RPMI/B27 minus insulin is used through day 5 and RPMI/B27 with insulin from day 7.
Literature source
Lian X et al. Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/β-catenin signaling under fully defined conditions. Nature Protocols 8, 162–175 (2013).
Source locator: Reagent setup, RPMI/B27 media; Box 1, Directed differentiation with Gsk3 inhibitor, Activin A and BMP4 (GiAB protocol), steps 3–8
Read the original source · DOI: 10.1038/nprot.2012.150
Editorial source check: 2026-11-09. Verify the original publication, actual stock concentrations and local safety requirements before use. Research use only; not clinical instructions.